CCCC vs NDSN · rev $35.6M vs P/E 31, rev $2.69B
C4 Therapeutics Inc (CCCC) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported NDSN revenue for 2024-10-31 was $2.69B. Net income was $467.3M. Revenue was up 2.3% from 2023-10-31 to 2024-10-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
CCCC currently screens at market cap $425.7M. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the CCCC and NDSN stock pages for the full models.
Not investment advice.